Lifestyle drugs are a diverse group of pharmaceuticals that treat the symptoms of chronic non-life-threatening conditions -symptoms that are also the by-products of natural ageing.
Lifestyle drugs provide immense medical benefits to sufferers, leading to visible improvements in symptoms and in overall quality of life.
They also provide significant and rapidly growing revenue streams for the pharmaceutical industry.
This new management report, The Lifestyle Drugs Outlook to 2007, defines and quantifies this market and provides an in-depth analysis of the products and strategies that will shape therapeutic and product sub-sectors to 2007.
Detailed case studies are used to illustrate the challenges and opportunities specific to this high-profile market.
The report's expert analysis will allow you to assess market potential for your company and help you to devise successful product development and marketing strategies.
A Practical Guide
The Lifestyle Drugs Outlook to 2007 will provide:
Case studies - investigating the factors behind over- and under-performing lifestyle drugs
In depth analysis of R&D pipelines and lifestyle drugs due to reach the market by 2007
Future forecasts - of the lifestyle drugs market, its sub-sectors and products along with drug development strategies and emerging market opportunities
Detailed discussion of the pathophysiology and prevalence of major and emerging lifestyle disorders
Examination of recent legislative changes that may affect reimbursement and commercial potential
The Value Proposition
Benefit from over 250 pages of expert insight and analysis, that will enable you to:
Understand the characteristics of lifestyle drugs and the specific opportunities and challenges they bring
Devise winning lifestyle drug development and marketing strategies
Utilise case studies to understand reimbursement issues and enhance your product's commercial potential
Boost revenues through a complete understanding of the role of the media and the Internet in lifestyle drug market dynamics
Quantify the markets for lifestyle drugs by therapy area and product class and forecast growth to 2007
The Answers to Your Questions
Lifestyle drugs
How are they defined and characterised? What are the main areas of R&D activity? What specific product management strategies are required? How can a lifestyle drug be propelled to blockbuster status?
